Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001384563 | SCV001584092 | pathogenic | Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency | 2020-04-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CTLA4 are known to be pathogenic (PMID: 25213377, 25329329). This variant has not been reported in the literature in individuals with CTLA4-related conditions. This variant is a gross deletion of the genomic region encompassing exon 1 of the CTLA4 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 1 of the CTLA4 gene. This is expected to result in an absent or disrupted protein product. |